B6N.Cg-Fustm3.1(FUS)Emcf/H

Status

Available to order

EMMA IDEM:13072
Citation informationRRID:IMSR_EM:13072 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6N.Cg-Fustm3.1(FUS)Emcf/H
Alternative nameC57BL/6NTac-Fus tm1.1(FUS)Emcf/H
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolFustm3.1(FUS)Emcf
Gene/Transgene symbolFus

Information from provider

ProviderElizabeth Fisher
Provider affiliationMammalian Genetics Unit, MRC Harwell Institute
Additional ownerThis strain is co-owned by UCL and MRC Harwell
Genetic informationMice carry the human fused in sarcoma (FUS) gene at the endogenous Fus locus. The Fus gene has been humanised (human orthologous sequence replacing mouse sequence), starting from the ATG start codon and including introns and 3' UTR.
Phenotypic informationHomozygous:
Homozygous mice are viable, fertile and produced at normal mendelian ratios. Survival is normal up to 18 months. No obvious motor, or other, phenotype.

Heterozygous:
Heterozygous mice are viable, fertile, and produced at normal mendelian ratios. Survival is normal up to 18 months. No obvious motor, or other, phenotype.
Breeding historyTargeting was performed in 129 R1 ES cells. Following germ-line transmission in mice, were modified and used for implantation. The line has now been backcrossed 7 times onto C57BL/6N. Further backcrosses are ongoing.
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased respiratory quotient / IMPC
  • increased prepulse inhibition / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • hypoplasia / IMPC
  • abnormal embryo size / IMPC
MGI phenotypes (gene matching)
  • small thymus / MGI
  • motor neuron degeneration / MGI
  • decreased motor neuron number / MGI
  • abnormal neuromuscular synapse morphology / MGI
  • small testis / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • abnormal gait / MGI
  • abnormal suckling behavior / MGI
  • impaired limb coordination / MGI
  • increased mortality induced by gamma-irradiation / MGI
  • postnatal growth retardation / MGI
  • reduced female fertility / MGI
  • male infertility / MGI
  • decreased litter size / MGI
  • premature death / MGI
  • no abnormal phenotype detected / MGI
  • lymphoid hypoplasia / MGI
  • abnormal immunoglobulin level / MGI
  • no phenotypic analysis / MGI
  • abnormal chromosome morphology / MGI
  • aneuploidy / MGI
  • chromosome breakage / MGI
  • decreased lymphocyte cell number / MGI
  • decreased B cell number / MGI
  • abnormal male meiosis / MGI
  • abnormal hippocampus pyramidal cell morphology / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • neonatal lethality, complete penetrance / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).